The goal of this pilot randomized controlled trial is to determine if a randomized controlled trial of a collaborative pharmacist-intensivist telehealth follow-up after intensive care unit discharge can feasibly be performed in patients who have survived a critical illness.
The study intervention will be telehealth follow-up appointments provided by clinical pharmacists at approximately one and three months post-hospital discharge. The purpose of the follow-up appointments will be to assess for post-intensive care syndrome and provide recommend interventions aimed at improving recovery
Participants will randomized to receive the study intervention or standard of care.
Adults 18-89 years of age
Required admission to either medical or surgical ICU
Respiratory failure requiring invasive mechanical ventilation of at least 24 hours during ICU stay; or ICU stay of at least 7 days
Anticipated discharge to home after hospitalization
Pregnancy
Incarceration/Imprisonment
Life expectancy less than 6 months or enrolled in hospice/palliative care
Anticipated discharge to skilled nursing facility, medical rehabilitation facility, or other long terms care facility
Parallel
Post-ICU Telehealth Follow-up
BehavioralThe post-ICU clinic follow-up will be conducted by a pharmacist via a telehealth visit. A collaborating physician (i.e. intensivist) will provide clinical support and oversight as needed. The appointments will be 30-60 minute telephone/video calls. Participants be assessed for PICS and recommended interventions to improve their care.
Completion of Post-ICU follow-up
Percentage of patients completing post-ICU follow-up
Quality of life at 6 months using the Short Form Survey (SF-36)
Medical Outcomes Study (MOS) 36-Item Short Form Health Survey (SF-36). Scores 0-100, higher scores indicating more favorable health state.
Hospital or ICU re-admissions
Emergency department visits
Mortality
Click on the lead sponsor to view all of their trials.
